Seasonal Influenza Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

Published April 19, 2023

DelveInsight’s Seasonal Influenza – Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Seasonal Influenza, historical and forecasted epidemiology as well as the Seasonal Influenza market trends in the United States, EU4 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The Seasonal Influenza market report provides current treatment practices, emerging drugs, and market share of individual therapies, and current and forecasted 7MM Seasonal Influenza market size from 2019 to 2032. The Report also covers current Seasonal Influenza treatment practice, market drivers, market barriers, SWOT analysis, reimbursement and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Key Facts of Seasonal Influenza Market Report

●In Japan, due to COVID-19, only 8,105 medical visits related to seasonal influenza were estimated in 2021, which are expected to rise.
●Influenza vaccination coverage was calculated for two age groups, 0-65 years and 65+ years. In 2021, the total vaccinated population is estimated to be 366,474,828 in the 7MM. The highest total vaccinated population was seen in the US.
●During the peak year of the COVID-19 pandemic, a steep decline in the cases of seasonal influenza was recorded throughout the 7MM. These cases are anticipated to rise again during the forecasted period (2022-2032).

Key Benefits of the Seasonal Influenza Market Report
●The report covers the descriptive overview of Seasonal Influenza, explaining its signs and symptoms, causes, classification, and currently available therapies.
●Comprehensive insight has been provided into Seasonal Influenza epidemiology and treatment.
●Additionally, an all-inclusive account of both the current and emerging therapies for Seasonal Influenza is provided, along with the assessment of new therapies which will have an impact on the current treatment landscape.
●A detailed review of the Seasonal Influenza market, historical and forecasted, is included in the report, covering the 7MM drug outreach.
●The report provides an edge while developing business strategies by understanding trends shaping and driving the 7MM Seasonal Influenza market.
Got queries? Click here to know more about the Seasonal Influenza Market Landscape

Seasonal Influenza Overview
Seasonal influenza is an acute viral infection that spreads easily from person to person, causing annual epidemics which peak during the winter in temperate regions of the world. Influenza can affect anyone, but some people, including the very young, the elderly, pregnant women, and those with underlying diseases, obesity, or a weakened immune system, are at higher risk of developing a severe infection, requiring hospitalization, and possibly leading to death.
There are four types of influenza viruses, A, B, C, and D. Influenza types A and B cause the majority of human infection annually and are responsible for seasonal epidemics. Influenza A viruses cause the most severe clinical disease and are the commonest cause of seasonal epidemics and pandemics in human populations. Seasonal influenza is characterized by a sudden onset of fever, cough (usually dry), headache, muscle and joint pain, severe malaise (feeling unwell), sore throat, and a runny nose. Most people recover from fever and other symptoms within a week without requiring medical attention. But influenza can cause severe illness or death, especially in people at high risk.

Seasonal Influenza Epidemiological Insights
●A novel influenza virus strain emerges every year and causes a flu epidemic, seasonal influenza. This flu represents one of the greatest threats to global health. The Centers for Disease Control and Prevention (CDC) utilizes modeling to determine how many flu-related illnesses, doctor visits, hospital stays, and fatalities were there during a particular season.
●In 2021, as per DelveInsight’s assessment, 11,235,325 medical visits related to seasonal influenza were estimated in the 7MM. These cases are projected to rise by 2032 at a reasonable Compound Annual Growth Rate (CAGR).
●In the EU-5, in 2021, Italy had the highest medical visits related to seasonal influenza with 2,937,446 cases, followed by France with 1,977,533 cases in the same year. On the other hand, Spain had the lowest medical visits of seasonal influenza as 228,686 cases in 2021.
●In 2021 the total hospitalized cases of seasonal influenza was 173,227 in 7MM which are expected to increase by 2032.

Seasonal Influenza Epidemiological Segmentation
●Total Seasonal Influenza medical visits
●Total Seasonal Influenza type-specific cases
●Total Seasonal Influenza hospital cases
●Total Seasonal Influenza vaccinated coverage cases

Seasonal Influenza Market Outlook
The Seasonal Influenza market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Seasonal Influenza market trends by analyzing the impact of current Seasonal Influenza therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Seasonal Influenza market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Seasonal Influenza market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Seasonal Influenza market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @ Seasonal Influenza Market Landscape

Seasonal Influenza Key Companies
●PepTcell Limited
●And many others

Seasonal Influenza Therapies
●QVLP vaccine

Table of Contents
1. Key Insights
2. Report Introduction
3. Executive Summary of Seasonal Influenza
4. Disease Background and Overview
5. Epidemiology and patient population
6. The United States
7. EU 5
8. Seasonal Influenza Emerging Therapies
9. Seasonal Influenza Market Outlook
10.Market Access and Reimbursement of Therapies
11. Appendix
12. Seasonal Influenza Report Methodology
13.DelveInsight Capabilities
14. Disclaimer
15. About DelveInsight

Click here to read more about Seasonal Influenza Market Landscape

Related Reports
Seasonal Influenza Epidemiology Forecast

DelveInsight’s “Seasonal Influenza – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Seasonal Influenza epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan

Trending Reports

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
City: Albany
State: New York
Country: United States